{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:08:37Z","timestamp":1782824917496,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.humpath.2013.07.016","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T19:03:12Z","timestamp":1379703792000},"page":"2711-2718","source":"Crossref","is-referenced-by-count":91,"title":["Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A)"],"prefix":"10.1016","volume":"44","author":[{"given":"Michelle","family":"Houang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Clarkson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"Sioson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne S.","family":"Elston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick J.","family":"Clifton-Bligh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Ranchere-Vince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Valerie","family":"Decouvelaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"de la Fouchardiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2013.07.016_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.07.016_bb0010","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2013.07.016_bb0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1480269","article-title":"Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia","volume":"148","author":"Larsson","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.humpath.2013.07.016_bb0020","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-021919","article-title":"Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia","volume":"88","author":"Nelson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2013.07.016_bb0025","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00016.2003","article-title":"FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization","volume":"285","author":"Quarles","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.humpath.2013.07.016_bb0030","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2013.07.016_bb0035","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2013.07.016_bb0040","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.humpath.2013.07.016_bb0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jc.2012-3642","article-title":"Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET\/CT","volume":"98","author":"Clifton-Bligh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2013.07.016_bb0050","doi-asserted-by":"crossref","first-page":"794","DOI":"10.5732\/cjc.011.10013","article-title":"Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature","volume":"30","author":"Hu","year":"2011","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.humpath.2013.07.016_bb0055","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/art.23278","article-title":"Tumor-induced osteomalacia: lessons learned","volume":"58","author":"Lewiecki","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.humpath.2013.07.016_bb0060","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3928\/0147-7447-20021101-21","article-title":"Phosphaturic mesenchymal tumor","volume":"25","author":"Siegel","year":"2002","journal-title":"Orthopedics"},{"key":"10.1016\/j.humpath.2013.07.016_bb0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.anndiagpath.2012.06.005","article-title":"Phosphaturic mesenchymal tumor: a report of 6 patients treated at a single institution and comparison with reported series","volume":"17","author":"Fatani","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2013.07.016_bb0070","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.tripleo.2009.07.005","article-title":"Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature","volume":"108","author":"Woo","year":"2009","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.humpath.2013.07.016_bb0075","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/PAS.0b013e3181aa2311","article-title":"RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia","volume":"33","author":"Bahrami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.07.016_bb0080","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jclinpath-2012-200852","article-title":"Frequent expression of fibroblast growth factor-23 (FGF23) mRNA in aneurysmal bone cysts and chondromyxoid fibromas","volume":"65","author":"Graham","year":"2012","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2013.07.016_bb0085","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/RLU.0b013e31818866bf","article-title":"Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia","volume":"33","author":"Duet","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.humpath.2013.07.016_bb0090","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","article-title":"Localisation of mesenchymal tumours by somatostatin receptor imaging","volume":"359","author":"Jan de Beur","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2013.07.016_bb0095","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/PAS.0b013e31823d07f3","article-title":"Somatostatin receptor subtype 2A immunohistochemistry using a new monoclonal antibody selects tumors suitable for in vivo somatostatin receptor targeting","volume":"36","author":"Korner","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.07.016_bb0100","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00259-011-1846-5","article-title":"Molecular imaging with (6)(8)Ga-SSTR PET\/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours","volume":"38","author":"Kaemmerer","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.humpath.2013.07.016_bb0105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bone.2006.07.027","article-title":"A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery","volume":"40","author":"Elston","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.humpath.2013.07.016_bb0110","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","article-title":"Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets","volume":"59","author":"Weidner","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.07.016_bb0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00223-010-9369-9","article-title":"The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels","volume":"86","author":"Ishii","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.humpath.2013.07.016_bb0120","doi-asserted-by":"crossref","unstructured":"Fischer T, Doll C, Jacobs S, et al. Reassessment of SST2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1. J Clin Endocrinol Metab 2008;93:4519-24.","DOI":"10.1210\/jc.2008-1063"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713003031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713003031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T15:17:22Z","timestamp":1646579842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817713003031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0046817713003031"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2013.07.016","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}